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In a retrospective study the results of medical thoracoscopy in 147 patients were reviewed; 136 of the patients had 
pleural effusion and 11 patients had diffuse pulmonary infiltration. All the pleural exudates were initially screened 
three times successively and found to be sterile and without tumour cells. All thoracoscopies were performed with 
local anaesthesia, with the ‘open technique’, and nine different doctors performed the thoracoscopies. The overall 
diagnostic sensitivity was 90.4%. The results demonstrated 62% with malignancy of the pleura, and 38% revealed 
benign pleural diseases, among them 2% with tuberculosis. The sensitivity for malignancy was found to be 88% and 
the specificity 96%. The most common primary lung cancer with involvement of the pleura was the adenocarcinoma 
(62%), and the most common metastatic tumour originated from the breast (28%). The sensitivity for tuberculosis 
was 100% and the specificity 100%. 
No mortality was found, and the morbidity was low at about 0.6% (empyema, pleuro-cutaneous fistula, 
transcutaneous growth of tumour (mesothelioma)). In 64% of the patients the thoracoscopy resulted in treatment 
(pleurodesis, antituberculous treatment, chemotherapy and peroral steroid therapy). 
The medical diagnostic thoracoscopy in local anaesthesia is a simple, low-cost investigation with a relatively high 
diagnostic accuracy, no mortality and a low morbidity. 
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Introduction 
Thoracoscopy was introduced by Jacobaeus in 1913 (l), 
and over the next five decades has been used mostly in 
the collapse treatment of tuberculosis (2). At present the 
elucidation and diagnosis of pleural effusion is the main 
indication for thoracoscopy (2,3) although it has been used 
in the diagnosis of diffuse pulmonary infiltrates as well (4). 
Only recently has the interest for therapeutic thoracoscopy 
increased with the development of video-assisted techniques 
(5), giving rise to the debate of thoracoscopy being a 
surgical or a medical domain (6-8). When the indication 
for thoracoscopy is related to the diagnosis of pleural 
effusion, and bioptic procedures for diffuse pulmonary 
infiltrates (‘lung fibrosis’), it seems to be a very safe and 
uncomplicated technique with a high diagnostic accuracy in 
the hand of the pulmonologist (4). 
The aim of this retrospective study was to render the 
statement true by controlling the 146 patients having 
‘medical’ thoracoscopy performed over a 5-year period. 
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Materials and Methods 
Patients 
During the period 1986 to 1992 a total of 147 patients 
underwent diagnostic thoracoscopy. In 1995 the patients 
were followed up in order to establish the correctness of 
the diagnosis. Death certificates, hospital records and 
autopsy reports were obtained concerning patients who had 
died during the period of observation. The microscopic 
diagnosis was built on the routine answers from the 
pathologist in the case records. 
A total of 78 patients were male and 69 were female; the 
mean age was 63 years (range 17-85). 
The mean FEV, was 1.76 1 (range 0.64.18, or the relative 
range 26-l 10%). No viral studies were done. 
I’ve-thoracoscopic Investigations 
Of the 147 patients, 136 had pleural effusion determined by 
chest X-ray and pleurocentesis. Some 11 patients had no 
pleural effusion and were suspected of pulmonary fibroses, 
but none of the patients revealed a honeycomb image of the 
lung by chest X-ray or end-stage interstitial fibrosis. These 
11 patients entered this study as a proportion of a simul- 
taneous parallel thoracoscopy study concerning patients 
suspected of idiopathic pulmonary fibrosis. In the 136 
patients with pleural effusion, diagnostic pleurocentesis was 
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performed three successive times and in all cases, the 
pleural fluid was found to be non-diagnostic - being an 
exudate (pleura protein >30 g l- ‘), sterile (bacteria and 
tubercle bacillus) and without tumour cells. A routine 
electrocardiogram with 12 leads showed no sign of recent 
myocardial infarction or significant arrythmia. Spirometry 
with Vitalograph”’ was performed as well. 
Thomcoscopic Technique 
Nine doctors with a varying experience in thoracoscopy 
performed the investigations. Contraindications for 
thoracoscopy were: hypocoagulopathy (prothrombin time 
<50%, and/or platelet count less than 40 000 platelets 
mm-3) and cardiological abnormalities and clinical 
signs of pulmonary hypertension. 
On the day of the thoracoscopy, pleurocentesis was per- 
formed, and while being in good cleavage with controlled 
respiratory fluctuations, pneumothorax was established by 
passively insufflating air from the atmosphere. 
An artificial pneumothorax was performed in the 11 
patients without pleural effusion and pneumothorax using 
the technique described by Faurschou (9). 
Premeditation: 1 h before thoracoscopy diazepam 10 mg 
p.o. was given followed by atropine 0.5 mg i.m. after 
another 30 min. A peripheral intravenous cannula was 
secured making it possible to administer, if necessary, a 
supplement of midazolam and/or analgesic. 
Oxygen 3 1 min ~ ’ via nasal cannula was administered 
during the entire procedure to prevent cardiac arrhythmias, 
hypotension and hypoxemia (10). 
After premeditation, the combined scope and forceps 
was inserted, under local anaesthesia, through a trocar with 
an outer diameter of 10 mm and without valve, in an 
intercostal space, with the patient resting on the 
healthy side (‘the open technique’). A sterile catheter was 
introduced through the trocar and the residual effusion was 
taken under sterile conditions. After the pleural cavity had 
been emptied, the lung and pleura were examined by way of 
the thoracoscope, and any atelectases, adherences, fibrin, 
discoloration of the pleura, hyperaemia, tuberculous 
nodules, formation of tumours, etc., were observed. The 
thoracoscope used was 0” or 30” rigid fiberoptic scope with 
spoon forceps for biopsy. 
Whenever feasible, biopsies were taken, placed immedi- 
ately in formalin, and sent for microscopic examination; 
in all cases, except those in which thoracoscopy showed 
that cancer was present, the effusions, and at least one 
biopsy, were examined for the presence of Mycobacterium 
tuberculosis at the State Serum Institute. About five to 15 
biopsies were taken from each patient from the parietal 
pleura depending on the macroscopic findings, and in 11 
patients suspected of pulmonary fibrosis only five biopsies 
were taken from the lung. 
Tube Drainage 
In the years 1986-1988 pleural drainage was not mandatory 
if no lung biopsies were taken (n=21), but after this period 
a suction drainage was always inserted to allow the lung 
to expand, to prevent subcutaneous emphysema and to 
perform pleurodesis if necessary (n= 125). The drainage was 
performed with a plastic tube of size CH 14. 
Statistics 
Descriptive statistics were used as well as sensitivity, 
specificity and predictive values of a positive/negative test. 
Sensitivity: 1-j’. Beta: the probability of a false negative. 
Specificity: l-a. Alpha: the probability of a false positive. 
PPI=positive predictive index= the predictive value of a 
positive test =the proportion of true positives among the 
apparent positives. 
NPI=negative predictive index=the predictive value of a 
negative test. 
Results 
DIAGNOSIS 
Malignancy 
Thoracoscopy was performed on 147 patients, and in 62% 
(n=91) resulted in a diagnosis of malignancy by this 
procedure. Primary lung/pleura cancer contributed with 
18%, and secondary cancer with 23%, and the mesothe- 
lioma represented 21% of the cases. Among the primary 
bronchogenic cancers the frequency of different histological 
types was: pulmonary adenocarcinoma (28%), squamous- 
cell carcinoma (lo%), small-cell carcinoma (4%) and 
large-cell carcinoma (4%). 
Non-malignancy 
In 38% (n=56) a non-malignant diagnosis was the result, 
out of which tuberculosis contributed only 2% (n= 3). In 
these cases parietal pleural biopsies revealed characteristic 
tuberculous granulomata. The non-diagnostic pleuritis con- 
tributed with 31% (451147 patients). Twelve of the 45 were 
false negative, so that, in 23% (33 patients), a diagnosis 
could not be established (‘idiopathic pleural effusions’). 
Details are shown in Table 1. 
Diagnostic Accuracy 
The overall diagnostic sensitivity was 90.4%, including the 
patients without any spedjic diagnosis. The pleuritis of 
these patients healed spontaneously within the time of 
observation (at least 2 years), which excludes more severe 
diseases of the pleura. 
The sensitivity for thoracoscopy and malignancy in our 
sample population was 88% ((89/89+ 12)*100), and the 
specificity was 95% ((43143 + 2)* 100). The predictive value 
of a positive malignant biopsy (PPI: positive predictive 
index) was 98%, and the predictive value of a negative 
biopsy (NPI: negative predictive index) was found to be 
78%. 
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TABLE 1. Diagnostic outcome of thoracoscopy in 147 patients 
Malignant (n=91; 62% of total) Benign (n=56; 38% of total) 
Primary lung cancer 26 (18% of total) 
Metastasis to pleura 34 (23% of total) 
Unspecific inflammation 45 (31% of total) 
Lupus erytomatosis disseminatus 2 1 
Idiopathic pulmonary fibrosis 2 
Rheumatoid pleuritis 1 i 
(4% of total) 
Sarcoidosis l- 1 
Primary pleura cancer (mesothelioma) 31 (21% of total) Tuberculosis 3 (2% of total) 
Eosinophilic granulomas 2 (1% of total) 
All patients kept a normal oxygen saturation under the 
thoracoscopy, and no patients required further midazolam 
and/or analgesic. 
The mean chest tube drainage time was 3.14 days (range 
l-lo), and for patients having pleurodesis the mean chest 
tube time was 6.47 days (range l-19). 
COMPLICATIONS 
No mortality was related to the thoracoscopy. No major 
bleeding from the biopsy sites or haemoptysis was 
observed. In one case a post-thoracoscopic empyema 
occurred (Staphylococcus aureus). No subcutaneous 
emphysema was observed. In one patient with an 
adenocarcinoma a subcutaneous fistula occurred and closed 
spontaneously only after 75 days. No vaso-vagal episodes 
with bradycardia were observed. Thus, the overall 
complication rate was 3% (5047) (Table 4). 
OUTCOME: CLINICAL CONSEQUENCE 
In 69% (n= 102) of the patients a specific diagnosis was 
established. In 67% (n=68) pleurodesis was performed, in 
16% (n= 16) chemotherapy was given, in 7% (n=7) oral 
steroids were given, in 3% (n = 3) antituberculous treatment 
was given, and in 7% (n = 7) no treatment was required. The 
indication for pleurodesis was malignant pleural exudate 
with subsequent need for pleurocentesis. Details are given 
in Table 2. 
Discussion 
The main indication for medical diagnostic thoracoscopy is 
exudative chronic pleural effusion of unknown aetiology, 
although it has also been used in the diagnosis of diffuse 
pulmonary infiltrates also (4). Cytological investigations of 
the fluid can reveal malignancy in approximately 50-60% 
of the cases of malignant pleural disease (2,4). ‘Blind’ needle 
pleural biopsy is characterized by low sensitivity (2). The 
overall diagnostic sensitivity in our material was 90.4%. The 
patients with chronic pleural exudation had three successive 
cytological investigations of the fluid which revealed no 
malignancy. By subsequently carrying out thoracoscopy, a 
diagnosis of malignancy was established with a sensitivity 
of 88% and a specificity of 95%. Bergqvist and Nordenstam 
TABLE 2. The secondary pleural cancers, differentiation and 
origins: differentiation of the primary lung cancers (n=26) 
Type Number (%I 
Adeno 16 61 
Squamous 6 23 
Small-cell 2 8 
Large-cell 2 8 
Mixed type 0 0 
Primary origin of the metastases (n=34) 
Origin Number (%) 
Mammae 10 28 
Colon 4 12 
Uterus 4 12 
Ovarium 4 12 
Prostate 2 6 
Ventricle 3 9 
Kidney 2 6 
Melanoma 2 6 
Thyroid gland 1 3 
Pancreas 1 3 
CLL 1 3 
CLL, chronic lymphatic leukaemia. 
(3) found a sensitivity of 89% in their material while the 
sensitivity was 69% in previous Danish material (11). In a 
review (12) a correct pathological diagnosis was achieved 
in 92.5%. The possible reasons for the variation of the 
sensitivity in malignancy of the pleura is discussed further 
in the review of Loddenkemper and Boutin (2). The 
specificity of 96% in our material is almost identical to the 
one reported by Brandt et al. (4). The most frequent 
primary lung cancer involving the pleural cavity was the 
adenocarcinoma (61%) while the most frequent metastatic 
tumour was breast cancer (28%). Tuberculosis was found in 
only 2% of our material but more important is the high 
specificity of 100% in accordance with other reports (4). 
One patient with rheumatoid arthritis and pleurisy dis- 
played the thoracoscopic characteristic macroscopic 
TABLE 3. Post-thoracoscopic therapeutic measures executed diseases and tuberculosis, which is also confirmed in our 
in 94 of the 147 patients (63.9%) material. 
Number 
Percentage 
of total 
Antituberculous treatment 3 2 
Peroral steroid treatment 7 5 
Chemotherapy 16 11 
Pleurodesis 68 46 
Total 94 64 
picture previously described by Faurschou et al. (13). The 
proportion of the so-called idiopathic pleural effusions in 
our material was 23% in accordance with Bergquist and 
Nordenstam (3). Enk et al. (11) found the number to 
be 30%, but other authors report the number to be 
below 10% (4). From a practical point of view this is not 
so important, whereas exclusion of malignancy and 
tuberculosis is essential and here the high sensitivity and 
specificity is important for both malignant pleural 
In 64% a post-thoracoscopic therapeutic measure was 
taken (Table 3). The complication rate was found to be low, 
especially with no mortality and no per-thoracoscopic 
bleeding (Table 4). In a review of, respectively, 8000 and 
4300 cases, others (14,15) have found the mortality rate to 
be between 0.01 and 0.09%. In 0.6% we observed empyema, 
pleurocutaneous fistula and transcutaneous growth of 
tumour, this low morbidity being identical to that reported 
elsewhere (14). Post-thoracoscopic radiotherapy has been 
done to prevent the disagreeable transcutaneous growth of 
tumour but was not used in our material (16). Medical 
thoracoscopy is a low-cost investigation compared to 
‘surgical’ thoracoscopy (Table 5). In conclusion 
medical diugnostic thoracoscopy, performed under local 
anaesthesia, is a simple relatively low-cost procedure with a 
high sensitivity and specificity, insignificant mortality and a 
very low morbidity. When doing the more complicated 
and expensive surgical thoracoscopy (video-assisted 
thoracoscopy (VAT)) for diagnostic purposes, it might offer 
advantages - but we need to know more about sensitivity, 
specificity, mortality, morbidity and cost in follow-up 
studies on a larger scale. 
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TABLE 4. Thoracoscopic complications. (n= 147 patients) 
Number 
Percentage 
of total 
Empyema (Staphylococcus aureus) 1 0.6 
Pleuro-cutaneous fistula 1 0.6 
Transcutaneous growth of tumour (mesothelioma) 1 0.6 
One additional chest tube needed after thoracoscopy 2 1.2 
Subcutaneous emphysema 0 
Bleeding 0 
Mortality 0 
TABLE 5. Cost estimate between medical thoracoscopy and interventional thoracoscopy* 
Interventional 
Medical 
diagnostic 
Medical doctor (number) 
Registered nurse (number) 
Anaesthesia 
Room 
Cost of equipment 
Length of procedure 
The length of hospital stay 
2-3 
43 
General 
Operating theatre 
500 000 (DKr) 
2h 
2 days 
1 
2 
Local 
Endoscopy room 
60 000 (DKr) 
lh 
2 days 
*The price of thoracoscopy depends on the number of people involved in the procedure, the length 
of the procedure, the price of the equipment, the room and the days spent in hospital. The ratio 
between personnel consumption in medical thoracoscopy and VATS is 1:3. 
The price of the VGT is probably three times as high as the diagnostic medical thoracoscopy. 
VGT, VATS, video assisted thoracoscopic surgery. 
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